Literature DB >> 32378138

Recent advances in understanding the role of hypoxia-inducible factor 1α in renal fibrosis.

Xuejiao Wei1, Xiaoyu Zhu1, Lili Jiang1, Xiu Huang1, Yangyang Zhang1, Dan Zhao1, Yujun Du2.   

Abstract

Renal fibrosis is the most common pathological manifestation of chronic kidney disease (CKD), and with numerous influencing factors, its pathogenesis is complex. Epithelial-mesenchymal transition (EMT) is known to promote the progression of renal fibrosis via alterations in the secreted proteome. Moreover, blocking or even reversing EMT can effectively reduce the degree of fibrosis. As such, targeting the key molecules responsible for promoting EMT may be an effective strategy for inhibiting renal fibrosis. Research in recent years has demonstrated that hypoxia-inducible factor 1α (HIF-1α) acts to promote renal fibrosis through regulation of EMT. However, the relationship between HIF-1α and EMT remains incompletely understood. In the present review, the underlying mechanism of the interaction between HIF-1α and EMT is explored to provide novel insight into the pathogenesis of renal fibrosis and new ideas for early targeted intervention.

Entities:  

Keywords:  Epithelial–mesenchymal transition; Hypoxia; Hypoxia-inducible factor-1α; Renal fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32378138     DOI: 10.1007/s11255-020-02474-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  4 in total

Review 1.  Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies.

Authors:  Lexin Liu; Qizhe Sun; Frank Davis; Jianhua Mao; Hailin Zhao; Daqing Ma
Journal:  Burns Trauma       Date:  2022-04-08

2.  Bioinformatics analysis of the potential regulatory mechanisms of renal fibrosis and the screening and identification of factors related to human renal fibrosis.

Authors:  Cixiao Wang; Shaobo Wu; Jiang Li; Yuexian Ma; Youqun Huang; Na Fang
Journal:  Transl Androl Urol       Date:  2022-06

3.  Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy.

Authors:  Fangfang Zheng; Peng Zhang; Mingzuo Zhao; Jinna Wang; Xiaohong Xu; Chi Zhang; Li Zhang
Journal:  Comput Math Methods Med       Date:  2022-08-08       Impact factor: 2.809

4.  Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy.

Authors:  Miho Shimizu; Kengo Furuichi; Shinji Kitajima; Tadashi Toyama; Megumi Oshima; Hisayuki Ogura; Koichi Sato; Shiori Nakagawa; Yuta Yamamura; Taro Miyagawa; Akinori Hara; Yasunori Iwata; Norihiko Sakai; Kiyoki Kitagawa; Mitsuhiro Yoshimura; Hitoshi Yokoyama; Takashi Wada
Journal:  BMC Nephrol       Date:  2021-09-25       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.